Showing 1181-1190 of 2524 results for "".
- New Serum Targets Menopausal Skin Changes with Plant-Based Technologyhttps://modernaesthetics.com/news/new-serum-targets-menopausal-skin-changes-with-plant-based-technology/2483594/In recognition of Menopause Awareness Month, skinbetter science® announced the release of Mystro Revive Renewing Serum, a new topical product aimed at addressing visible skin changes associated with perimenopause and menopause.
- Dr. Anthony Brissett Named President of AAFPRS for 2025–2026 Termhttps://modernaesthetics.com/news/dr-anthony-brissett-named-president-of-aafprs/2483515/Anthony E. Brissett, MD, FACS, a facial plastic and reconstructive surgeon based in Houston, has been named President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) for the 2025–2026 term. His appointment was formalized during the AAFPRS Annual Business Meeting held
- Neuvian Skincare Granted US Patent for Dual-Peptide Complexhttps://modernaesthetics.com/news/neuvian-skincare-granted-us-patent-for-dual-peptide-complex/2483373/Neuvian Skincare has received a US patent for its dual-peptide formulation targeting inflammatory skin conditions such as wounds, scars, and eczema, according to a press release. The patent (No. 12,377,156 B2), issued for “Compositions and Methods for Treatment of Wounds and Inflammatory Skin Con
- Noninvasive Brain Stimulation for Mental Wellness Coming to Illinois Dermatology Clinichttps://modernaesthetics.com/news/noninvasive-brain-stimulation-mental-wellness-coming-illinois-dermatology-clinic/2482956/An Illinois dermatology clinic is now offering a noninvasive brain stimulation treatment for patients experiencing depression, anxiety, and related mental health concerns. Dundee Dermatology recently introduced EXOMIND, a transcranial magnetic stimulation (TMS) device that is FDA
- Allergan Aesthetics Announces New ‘Faces of Natrelle’ Campaignhttps://modernaesthetics.com/news/allergan-aesthetics-announces-new-faces-of-natrelle-campaign/2476065/Allergan Aesthetics, an AbbVie company, has introduced “Faces of Natrelle,” a campaign centered on patient narratives surrounding breast augmentation and reconstruction using Natrelle silicone-filled breast implants. The initiative features 9 women selected through a national casting call,
- Alma Launches AI-Assisted Skincare System with Nearly 12M Formulation Optionshttps://modernaesthetics.com/news/alma-launches-ai-assisted-skincare-system-with-nearly-12m-formulation-options/2475858/Alma has launched Universkin by Alma, a new AI-assisted medical-grade skincare platform designed to support physicians in offering personalized treatment regimens. The system enables rapid clinical assessment and tailored formulation of topical therapies using an intelligent diagnostic algorithm
- Obagi Medical Acquires Novaestiq to Introduce HA Injectables in US Markethttps://modernaesthetics.com/news/obagi-medical-acquires-novaestiq-to-introduce-ha-injectables-in-us-market/2475814/Obagi Medical is set to expand into aesthetic injectables following the acquisition of Novaestiq Corp., the company behind the Saypha® ChIQ™ and Saypha® MagIQ™ hyaluronic acid (HA) filler products. The transaction was completed by Obagi’s parent company, Waldencast
- CollPlant Appoints Bowman Bagley to Lead North American Commercial Operationshttps://modernaesthetics.com/news/collplant-appoints-bowman-bagley-to-lead-north-american-commercial-operations/2475724/CollPlant Biotechnologies has appointed Bowman Bagley as Vice President, Commercial North America, a newly established role aimed at expanding the company’s commercial presence and operations in the region. Bagley will oversee sales, marketing, lo
- New Research Evaluates Nonsurgical Rhinoplasty Using HA Filler in Asian Patientshttps://modernaesthetics.com/news/new-research-evaluates-nonsurgical-rhinoplasty-using-ha-filler-in-asian-patients/2475629/Newly published data in the Plastic and Aesthetic Nursing journal indicates the anatomical and procedural nuances that are critical for achieving optimal results in nonsurgical rhinoplasty (NSR) using hyaluronic acid (HA) dermal filler. Authors Jovian Wan, MBChB, and Kyu-Ho Yi, MD, PhD,
- FDA Reviews sPMA Application for Hyaluronic Acid Injectable to Improve Neck Appearancehttps://modernaesthetics.com/news/fda-reviews-spma-application-for-hyaluronic-acid-injectable-to-improve-neck-appearance/2475595/The U.S. Food and Drug Administration (FDA) has accepted for review a supplemental premarket approval (sPMA) application for SKINVIVE by JUVÉDERM® (Allergan Aesthetics, an AbbVie company), expanding its potential use to include treatment of horizontal neck lines in